187 related articles for article (PubMed ID: 23362087)
1. Pyk2 regulates megakaryocyte-induced increases in osteoblast number and bone formation.
Cheng YH; Hooker RA; Nguyen K; Gerard-O'Riley R; Waning DL; Chitteti BR; Meijome TE; Chua HL; Plett AP; Orschell CM; Srour EF; Mayo LD; Pavalko FM; Bruzzaniti A; Kacena MA
J Bone Miner Res; 2013 Jun; 28(6):1434-45. PubMed ID: 23362087
[TBL] [Abstract][Full Text] [Related]
2. Megakaryocytes regulate expression of Pyk2 isoforms and caspase-mediated cleavage of actin in osteoblasts.
Kacena MA; Eleniste PP; Cheng YH; Huang S; Shivanna M; Meijome TE; Mayo LD; Bruzzaniti A
J Biol Chem; 2012 May; 287(21):17257-17268. PubMed ID: 22447931
[TBL] [Abstract][Full Text] [Related]
3. Pyk2 and Megakaryocytes Regulate Osteoblast Differentiation and Migration Via Distinct and Overlapping Mechanisms.
Eleniste PP; Patel V; Posritong S; Zero O; Largura H; Cheng YH; Himes ER; Hamilton M; Ekwealor JTB; Kacena MA; Bruzzaniti A
J Cell Biochem; 2016 Jun; 117(6):1396-406. PubMed ID: 26552846
[TBL] [Abstract][Full Text] [Related]
4. Signaling pathways involved in megakaryocyte-mediated proliferation of osteoblast lineage cells.
Cheng YH; Streicher DA; Waning DL; Chitteti BR; Gerard-O'Riley R; Horowitz MC; Bidwell JP; Pavalko FM; Srour EF; Mayo LD; Kacena MA
J Cell Physiol; 2015 Mar; 230(3):578-86. PubMed ID: 25160801
[TBL] [Abstract][Full Text] [Related]
5. Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.
Posritong S; Hong JM; Eleniste PP; McIntyre PW; Wu JL; Himes ER; Patel V; Kacena MA; Bruzzaniti A
Mol Cell Endocrinol; 2018 Oct; 474():35-47. PubMed ID: 29428397
[TBL] [Abstract][Full Text] [Related]
6. The role of gap junctions in megakaryocyte-mediated osteoblast proliferation and differentiation.
Ciovacco WA; Goldberg CG; Taylor AF; Lemieux JM; Horowitz MC; Donahue HJ; Kacena MA
Bone; 2009 Jan; 44(1):80-6. PubMed ID: 18848655
[TBL] [Abstract][Full Text] [Related]
7. Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation.
Ciovacco WA; Cheng YH; Horowitz MC; Kacena MA
J Cell Biochem; 2010 Mar; 109(4):774-81. PubMed ID: 20052670
[TBL] [Abstract][Full Text] [Related]
8. C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis.
Meijome TE; Ekwealor JTB; Hooker RA; Cheng YH; Ciovacco WA; Balamohan SM; Srinivasan TL; Chitteti BR; Eleniste PP; Horowitz MC; Srour EF; Bruzzaniti A; Fuchs RK; Kacena MA
J Cell Biochem; 2016 Apr; 117(4):959-69. PubMed ID: 26375403
[TBL] [Abstract][Full Text] [Related]
9. Megakaryocyte and Osteoblast Interactions Modulate Bone Mass and Hematopoiesis.
Alvarez MB; Xu L; Childress PJ; Maupin KA; Mohamad SF; Chitteti BR; Himes E; Olivos DJ; Cheng YH; Conway SJ; Srour EF; Kacena MA
Stem Cells Dev; 2018 May; 27(10):671-682. PubMed ID: 29631496
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocytes promote bone formation through coupling osteogenesis with angiogenesis by secreting TGF-β1.
Tang Y; Hu M; Xu Y; Chen F; Chen S; Chen M; Qi Y; Shen M; Wang C; Lu Y; Zhang Z; Zeng H; Quan Y; Wang F; Su Y; Zeng D; Wang S; Wang J
Theranostics; 2020; 10(5):2229-2242. PubMed ID: 32104505
[No Abstract] [Full Text] [Related]
11. Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2.
Kacena MA; Shivdasani RA; Wilson K; Xi Y; Troiano N; Nazarian A; Gundberg CM; Bouxsein ML; Lorenzo JA; Horowitz MC
J Bone Miner Res; 2004 Apr; 19(4):652-60. PubMed ID: 15005853
[TBL] [Abstract][Full Text] [Related]
12. Megakaryocyte-mediated inhibition of osteoclast development.
Kacena MA; Nelson T; Clough ME; Lee SK; Lorenzo JA; Gundberg CM; Horowitz MC
Bone; 2006 Nov; 39(5):991-999. PubMed ID: 16782418
[TBL] [Abstract][Full Text] [Related]
13. Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival.
Lim ST; Miller NL; Nam JO; Chen XL; Lim Y; Schlaepfer DD
J Biol Chem; 2010 Jan; 285(3):1743-53. PubMed ID: 19880522
[TBL] [Abstract][Full Text] [Related]
14. Lnk Deficiency Leads to TPO-Mediated Osteoclastogenesis and Increased Bone Mass Phenotype.
Olivos DJ; Alvarez M; Cheng YH; Hooker RA; Ciovacco WA; Bethel M; McGough H; Yim C; Chitteti BR; Eleniste PP; Horowitz MC; Srour EF; Bruzzaniti A; Fuchs RK; Kacena MA
J Cell Biochem; 2017 Aug; 118(8):2231-2240. PubMed ID: 28067429
[TBL] [Abstract][Full Text] [Related]
15. Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis.
Buckbinder L; Crawford DT; Qi H; Ke HZ; Olson LM; Long KR; Bonnette PC; Baumann AP; Hambor JE; Grasser WA; Pan LC; Owen TA; Luzzio MJ; Hulford CA; Gebhard DF; Paralkar VM; Simmons HA; Kath JC; Roberts WG; Smock SL; Guzman-Perez A; Brown TA; Li M
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10619-24. PubMed ID: 17537919
[TBL] [Abstract][Full Text] [Related]
16. Megakaryocytes are mechanically responsive and influence osteoblast proliferation and differentiation.
Soves CP; Miller JD; Begun DL; Taichman RS; Hankenson KD; Goldstein SA
Bone; 2014 Sep; 66():111-20. PubMed ID: 24882736
[TBL] [Abstract][Full Text] [Related]
17. Megakaryocyte-bone cell interactions.
Kacena MA; Ciovacco WA
Adv Exp Med Biol; 2010; 658():31-41. PubMed ID: 19950013
[TBL] [Abstract][Full Text] [Related]
18. A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells.
Kacena MA; Gundberg CM; Horowitz MC
Bone; 2006 Nov; 39(5):978-984. PubMed ID: 16860008
[TBL] [Abstract][Full Text] [Related]
19. Aging negatively impacts the ability of megakaryocytes to stimulate osteoblast proliferation and bone mass.
Maupin KA; Himes ER; Plett AP; Chua HL; Singh P; Ghosh J; Mohamad SF; Abeysekera I; Fisher A; Sampson C; Hong JM; Childress P; Alvarez M; Srour EF; Bruzzaniti A; Pelus LM; Orschell CM; Kacena MA
Bone; 2019 Oct; 127():452-459. PubMed ID: 31299382
[TBL] [Abstract][Full Text] [Related]
20. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
